title: 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity).
abstract: The 2016 10th Workshop on Recent Issues in Bioanalysis (10th WRIB) took place in Orlando, Florida with participation of close to 700 professionals from pharmaceutical/biopharmaceutical companies, biotechnology companies, contract research organizations, and regulatory agencies worldwide. WRIB was once again a weeklong event - A Full Immersion Week of Bioanalysis for PK, Biomarkers and Immunogenicity. As usual, it is specifically designed to facilitate sharing, reviewing, discussing and agreeing on approaches to address the most current issues of interest including both small and large molecules involving LCMS, hybrid LBA/LCMS, and LBA approaches, with the focus on PK, biomarkers and immunogenicity. This 2016 White Paper encompasses recommendations emerging from the extensive discussions held during the workshop, and is aimed to provide the bioanalytical community with key information and practical solutions on topics and issues addressed, in an effort to enable advances in scientific excellence, improved quality and better regulatory compliance. This White Paper is published in 3 parts due to length. This part (Part 3) discusses the recommendations for large molecule bioanalysis using LBA, biomarkers and immunogenicity. Parts 1 (small molecule bioanalysis using LCMS) and Part 2 (Hybrid LBA/LCMS and regulatory inputs from major global health authorities) have been published in the Bioanalysis journal, issues 22 and 23, respectively.
authors.affiliation: Sanofi, Framingham, MA, USA.
authors.forename: Susan
authors.initials: S
authors.lastname: Richards
authors.affiliation: Sanofi, Framingham, MA, USA.
authors.forename: Lakshmi
authors.initials: L
authors.lastname: Amaravadi
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Renuka
authors.initials: R
authors.lastname: Pillutla
authors.affiliation: Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland.
authors.forename: Herbert
authors.initials: H
authors.lastname: Birnboeck
authors.affiliation: Regeneron Pharmaceuticals, Tarrytown, NY, USA.
authors.forename: Albert
authors.initials: A
authors.lastname: Torri
authors.affiliation: Genentech, South San Francisco, CA, USA.
authors.forename: Kyra J
authors.initials: KJ
authors.lastname: Cowan
authors.affiliation: Roche Pharma Research and Early Development, Roche Innovation Center, Munich, Germany.
authors.forename: Apollon
authors.initials: A
authors.lastname: Papadimitriou
authors.affiliation: Angelini Pharma, Pomezia, RM, Italy.
authors.forename: Fabio
authors.initials: F
authors.lastname: Garofolo
authors.affiliation: Charles River, Reno, NV, USA.
authors.forename: Christina
authors.initials: C
authors.lastname: Satterwhite
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Steven
authors.initials: S
authors.lastname: Piccoli
authors.affiliation: Janssen R&D, Spring House, PA, USA.
authors.forename: Bonnie
authors.initials: B
authors.lastname: Wu
authors.affiliation: Bioagilytix Labs, Durham, NC, USA.
authors.forename: Corinna
authors.initials: C
authors.lastname: Krinos-Fiorotti
authors.affiliation: LGC, Cambridge, UK.
authors.forename: John
authors.initials: J
authors.lastname: Allinson
authors.affiliation: Daiichi Sankyo, Edison, NJ, USA.
authors.forename: Flora
authors.initials: F
authors.lastname: Berisha
authors.affiliation: Health Canada, Ottawa, ON, Canada.
authors.forename: Laurent
authors.initials: L
authors.lastname: Cocea
authors.affiliation: WHO, Geneva, Switzerland.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Croft
authors.affiliation: Pfizer, Groton, CT, USA.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Fraser
authors.affiliation: Italy AIFA, Rome, Italy.
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Galliccia
authors.affiliation: Pfizer, Andover, MA, USA.
authors.forename: Boris
authors.initials: B
authors.lastname: Gorovits
authors.affiliation: Allergan, Irvine, CA, USA.
authors.forename: Swati
authors.initials: S
authors.lastname: Gupta
authors.affiliation: Genentech, South San Francisco, CA, USA.
authors.forename: Vinita
authors.initials: V
authors.lastname: Gupta
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: Sam
authors.initials: S
authors.lastname: Haidar
authors.affiliation: GlaxoSmithKline, Paoli, PA, USA.
authors.forename: Charles
authors.initials: C
authors.lastname: Hottenstein
authors.affiliation: Japan MHLW-NIHS, Tokyo, Japan.
authors.forename: Akiko
authors.initials: A
authors.lastname: Ishii-Watabe
authors.affiliation: Pfizer, Andover, MA, USA.
authors.forename: Darshana
authors.initials: D
authors.lastname: Jani
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: John
authors.initials: J
authors.lastname: Kadavil
authors.affiliation: Eurofins Bioanalytical Services, St Charles, MO, USA.
authors.forename: John
authors.initials: J
authors.lastname: Kamerud
authors.affiliation: Sanofi, Frankfurt am Main, Germany.
authors.forename: Daniel
authors.initials: D
authors.lastname: Kramer
authors.affiliation: Covance, Indianapolis, IN, USA.
authors.forename: Virginia
authors.initials: V
authors.lastname: Litwin
authors.affiliation: Brazil Anvisa, Brasilia, Brazil.
authors.forename: Gustavo Mendes
authors.initials: GM
authors.lastname: Lima Santos
authors.affiliation: Novimmune, Geneva, Switzerland.
authors.forename: Robert
authors.initials: R
authors.lastname: Nelson
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Yan
authors.initials: Y
authors.lastname: Ni
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: João
authors.initials: J
authors.lastname: Pedras-Vasconcelos
authors.affiliation: Shire, Lexington, MA, USA.
authors.forename: Yongchang
authors.initials: Y
authors.lastname: Qiu
authors.affiliation: Q2 Solutions, Marietta, GA, USA.
authors.forename: Paul
authors.initials: P
authors.lastname: Rhyne
authors.affiliation: Bioagilytix Labs, Durham, NC, USA.
authors.forename: Afshin
authors.initials: A
authors.lastname: Safavi
authors.affiliation: Japan MHLW-NIHS, Tokyo, Japan.
authors.forename: Yoshiro
authors.initials: Y
authors.lastname: Saito
authors.affiliation: CFABS, Laval, QC, Canada.
authors.forename: Natasha
authors.initials: N
authors.lastname: Savoie
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: Kara
authors.initials: K
authors.lastname: Scheibner
authors.affiliation: Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland.
authors.forename: Eginhard
authors.initials: E
authors.lastname: Schick
authors.affiliation: Genentech, South San Francisco, CA, USA.
authors.forename: Patricia Y
authors.initials: PY
authors.lastname: Siguenza
authors.affiliation: UCB Biopharma, Braine L'Alleud, Belgium.
authors.forename: John
authors.initials: J
authors.lastname: Smeraglia
authors.affiliation: Roche Pharma Research and Early Development, Roche Innovation Center, Munich, Germany.
authors.forename: Roland F
authors.initials: RF
authors.lastname: Staack
authors.affiliation: Biogen, Cambridge, MA, USA.
authors.forename: Meena
authors.initials: M
authors.lastname: Subramanyam
authors.affiliation: Regeneron Pharmaceuticals, Tarrytown, NY, USA.
authors.forename: Giane
authors.initials: G
authors.lastname: Sumner
authors.affiliation: Amgen, Thousand Oaks, CA, USA.
authors.forename: Theingi
authors.initials: T
authors.lastname: Thway
authors.affiliation: Janssen R&D, Spring House, PA, USA.
authors.forename: David
authors.initials: D
authors.lastname: Uhlinger
authors.affiliation: EMD Serono, Aubonne, Switzerland.
authors.forename: Martin
authors.initials: M
authors.lastname: Ullmann
authors.affiliation: Novartis Pharma, Basel, Switzerland.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Vitaliti
authors.affiliation: Dutch MEB, Utrecht, The Netherlands.
authors.forename: Jan
authors.initials: J
authors.lastname: Welink
authors.affiliation: Aduro Biotech, Berkeley, CA, USA.
authors.forename: Chan C
authors.initials: CC
authors.lastname: Whiting
authors.affiliation: Pfizer, Andover, MA, USA.
authors.forename: Li
authors.initials: L
authors.lastname: Xue
authors.affiliation: OncoMed Pharmaceuticals, Redwood City, CA, USA.
authors.forename: Rong
authors.initials: R
authors.lastname: Zeng
mesh_terms: D000911:Antibodies, Monoclonal / Q000032:analysis / Q000276:immunology / Q000493:pharmacokinetics; D015415:Biomarkers / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid; D003245:Consensus Statements as Topic; D006077:Government Agencies; D006801:Humans; D008024:Ligands; D046911:Macromolecular Substances / Q000032:analysis / Q000276:immunology / Q000493:pharmacokinetics; D013058:Mass Spectrometry; D054928:Validation Studies as Topic
chemical_list: D000911:Antibodies, Monoclonal; D015415:Biomarkers; D008024:Ligands; D046911:Macromolecular Substances